Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes

Neurology

Volumn 85, Issue 5, 2015, Pages 450-458

  Chung, Chen Chih ^a,b   Pimentel, Daniela ^a   Jor'Dan, Azizah J ^a,c   Hao, Ying ^a,e   Milberg, William ^d   Novak, Vera ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; HEMOGLOBIN A1C; HYDROCORTISONE; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN PERFUSION; CEREBRAL VASOREGULATION; COGNITION; DAILY LIFE ACTIVITY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIN LABELING; VASOCONSTRICTION; VASODILATATION; VERY ELDERLY; BLOOD; BRAIN CIRCULATION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84938587545     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001820     Document Type: Article

References (32)

1. Bordier L, Doucet J, Boudet J, Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab 2014;40:331-337.
2. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004; 63:1181-1186.
3. Novak V, Zhao P, Manor B, et al. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care 2011;34:2438-2441.
4. Tsao CW, Seshadri S, Beiser AS, et al. Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology 2013;81:984-991.
5. Mehrabian S, Raycheva M, Gateva A, et al. Cognitive dysfunction profile and arterial stiffness in type 2 diabetes. J Neurol Sci 2012;322:152-156.
6. Heaton RK, Akshoomoff N, Tulsky D, et al. Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults. J Int Neuropsychol Soc 2014; 20:588-598.
7. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010;20: 871-880.
8. Detre JA, Alsop DC, Vives LR, Maccotta L, Teener JW, Raps EC. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50: 633-641.
9. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30: 1193-1199.
10. Zhao P, Alsop DC, Abduljalil A, et al. Vasoreactivity and peri-infarct hyperintensities in stroke. Neurology 2009;72: 643-649.
11. Zeng SM, Yankowitz J, Widness JA, Strauss RG. Etiology of differences in hematocrit between males and females: sequence-based polymorphisms in erythropoietin and its receptor. J Gend Specif Med 2001;4:35-40.
12. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-2713.
13. Luchsinger JA. Type 2 diabetes cognitive impairment: linking mechanisms. J Alzheimers Dis 2012;30(suppl 2): S185-S198.
14. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74.
15. Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011;77:1351-1356.
16. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147-152.
17. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-1572.
18. McNay EC, Cotero VE. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol Behav 2010;100:234-238.
19. Shorr RI, de Rekeneire N, Resnick HE, et al. Glycemia and cognitive function in older adults using glucoselowering drugs. J Nutr Health Aging 2006;10:297-301.
20. Luchsinger JA, Palmas W, Teresi JA, et al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging 2011;15:445-449.
21. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012;69:1170-1175.
22. Cantin S, Villien M, Moreaud O, et al. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI. Neuroimage 2011;58:579-587.
23. Lavi S, Gaitini D, Milloul V, Jacob G. Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2006;291:H1856-H1861.
24. Zhang P, Huang G, Shi X. Cerebral vasoreactivity during hypercapnia is reset by augmented sympathetic influence. J Appl Physiol 2011;110:352-358.
25. Lasek-Bal A, Kazibutowska Z, Goba A, Motta E. Cerebral vasoreactivity in hypocapnia and hypercapnia in patients with diabetes mellitus type 2 with or without arterial hypertension. Neurol Neurochir Pol 2012;46:529-535.
26. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
27. Kevil CG, Orr AW, Langston W, et al. Intercellular adhesion molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway. J Biol Chem 2004;279:19230-19238.
28. Kevil CG, Pruitt H, Kavanagh TJ, et al. Regulation of endothelial glutathione by ICAM-1: implications for inflammation. FASEB J 2004;18:1321-1323.
29. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517-519.
30. Mäkimattila S, Yki-Järvinen H. Endothelial dysfunction in human diabetes. Curr Diab Rep 2002;2:26-36.
31. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003; 74:70-76.
32. Tilvis RS, Kähönen-Väre MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 2004;59:268-274.